14 July 2014 - Deborah Wilkes
Archived
Italy's Rottapharm Madaus has abandoned its Initial Public Offering (IPO) on the Borsa Italiana, citing unfavourable market conditions.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.